A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).

被引：0
|
作者：
Ando, Kiyoshi
Ogura, Michinori
Suzuki, Tatsuya
Ishizawa, Kenichi
Oh, Sung Yong
Kim, Won Seog
Tanaka, Yoshinobu
Shimamoto, Takashi
Tobinai, Kensei
机构：
[1] Tokai Univ, Dept Hematol & Oncol, Hiratsuka, Kanagawa 25912, Japan
[2] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan
[3] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[4] Dong A Univ, Coll Med, Dept Internal Med, Pusan, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[6] MSD KK, Tokyo, Japan
[7] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ogura, Michinori
    Ando, Kiyoshi
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Itoh, Kuniaki
    Yamamoto, Kazuhito
    Au, Wing Yan
    Tien, Hwei-Fang
    Matsuno, Yoshihiro
    Terauchi, Takashi
    Yamamoto, Keiko
    Mori, Masahiko
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    Kim, Won Seog
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 768 - 776
  • [2] Bendamustine Is Highly Effective for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle Cell Lymphoma (MCL): Final Results of a Japanese Multicenter Phase II Study.
    Ogura, Michinori
    Uchida, Toshiki
    Ando, Kiyoshi
    Ohmachi, Ken
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    BLOOD, 2009, 114 (22) : 1422 - 1422
  • [3] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [4] Multicenter phase II study of oral fludarabine phosphate (FAMP) in relapsed indolent B-cell non-Hodgkin lymphoma (B-NHL)
    Morishima, Y
    Ogura, M
    Tobinai, K
    Minami, H
    Hayashi, M
    Hotta, T
    ANNALS OF ONCOLOGY, 2005, 16 : 155 - 155
  • [5] Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
    Kirschbaum, Mark
    Frankel, Paul
    Popplewell, Leslie
    Zain, Jasmine
    Delioukina, Maria
    Pullarkat, Vinod
    Matsuoka, Deron
    Pulone, Bernadette
    Rotter, Arnold J.
    Espinoza-Delgado, Igor
    Nademanee, Auayporn
    Forman, Stephen J.
    Gandara, David
    Newman, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1198 - 1203
  • [6] A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma (vol 165, pg 768, 2014)
    Ogura, Michinori
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (04) : 629 - 629
  • [7] Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study
    Yosuke Matsumoto
    Tsutomu Kobayashi
    Yuji Shimura
    Eri Kawata
    Hisao Nagoshi
    Muneo Ohshiro
    Mio Sugitani
    Kazuho Shimura
    Toshiki Iwai
    Shin-ichi Fuchida
    Mihoko Yoshida
    Miki Kiyota
    Shinsuke Mizutani
    Yoshiaki Chinen
    Tomoko Takimoto-Shimomura
    Mitsushige Nakao
    Hiroto Kaneko
    Hitoji Uchiyama
    Nobuhiko Uoshima
    Hikari Nishigaki
    Yutaka Kobayashi
    Shigeo Horiike
    Chihiro Shimazaki
    Masafumi Taniwaki
    Junya Kuroda
    International Journal of Hematology, 2019, 110 : 77 - 85
  • [8] Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study
    Matsumoto, Yosuke
    Kobayashi, Tsutomu
    Shimura, Yuji
    Kawata, Eri
    Nagoshi, Hisao
    Ohshiro, Muneo
    Sugitani, Mio
    Shimura, Kazuho
    Iwai, Toshiki
    Fuchida, Shin-ichi
    Yoshida, Mihoko
    Kiyota, Miki
    Mizutani, Shinsuke
    Chinen, Yoshiaki
    Takimoto-Shimomura, Tomoko
    Nakao, Mitsushige
    Kaneko, Hiroto
    Uchiyama, Hitoji
    Uoshima, Nobuhiko
    Nishigaki, Hikari
    Kobayashi, Yutaka
    Horiike, Shigeo
    Shimazaki, Chihiro
    Taniwaki, Masafumi
    Kuroda, Junya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (01) : 77 - 85
  • [9] Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial
    Friedberg, Jonathan W.
    Vose, Julie M.
    Kelly, Jennifer L.
    Young, Faith
    Liesveld, Jane
    Armitage, James O.
    Proia, Nicole
    Cruttenden, Kim
    Leonard, John P.
    BLOOD, 2009, 114 (22) : 381 - 381
  • [10] Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ogura, Michinori
    Uchida, Toshiki
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Watanabe, Takashi
    Kasai, Masanobu
    Matsumoto, Yosuke
    Shimizu, Daisuke
    Ogawa, Yoshiaki
    Ohmachi, Ken
    Yokoyama, Hiroki
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2054 - 2058
12345